McDonald's Stock Plunges Over 30% Amid Affordability Concerns
McDonald's stock has experienced a significant dip, falling more than 30% from its peak in February. This unusual volatility for a low-beta stock like MCD makes it an attractive buy opportunity.
The recent sell-off was triggered by concerns over affordability and the impact of glucagon-like peptide-1 (GLP-1) drugs on consumer behavior. McDonald's data shows that 84% of households with GLP-1 users still visit its restaurants, but these customers may be visiting less often or ordering smaller portions.
The company's management has responded to these challenges with the NEXT initiative, aiming to improve restaurant economics and recover traffic without relying on higher prices. The plan includes adding efficiency and generating $100,000 more in annual cash flow per U.S. restaurant.
With shares trading near $231, McDonald's valuation is now lower than its five-year average P/E of 24.5x. The dividend yield has also increased to around 3.2%, but this alone may not be enough to support the bull case. Analysts remain cautious, with a Moderate Buy rating and an average price target of $297.96, implying 28.92% upside from the current share price.